ScreenerHero
OSEOSE Immunotherapeutics SA
EPA · FR · Healthcare · Biotechnology · ose-immuno.com
3.316EUR+0.06%Mkt Cap: 85.77M $P/E: —

OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally. The company's products include Tedopi tha…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap85.77M $
Enterprise Value71.38M $
Revenue (TTM)2.92M $
Gross Profit2.59M $
Net Income (TTM)-40.97M $
Revenue/Share0.1315 USD
Last Price3.316 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2024
Employees64
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0012127173
Valuation
P/E (Trailing)—
P/E (Forward)-2.94
PEG—
EV/EBITDA-1.76
EV/Revenue24.40
P/S29.41
P/B2.70
EPS (TTM)-1.69
EPS (Forward)-1.14
52W Range
2.8729% of range7.700
52W High7.700 EUR
52W Low2.872 EUR
Profitability
Gross Margin88.70%
Oper. Margin-2272.16%
EBITDA Margin0.00%
Profit Margin-1439.06%
ROE-135.78%
ROA-47.79%
Growth
Revenue Growth-0.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-37.00M $
CapEx (TTM)106.52K $
FCF Margin-662.85%
FCF Yield-22.60%
Net Debt-14.11M $
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity1.27
Current Ratio1.28
Quick Ratio1.17
Book Value/Sh1.238 EUR
Cash/Share2.513 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)12.70 EUR
Upside (mean)+283.0%
Target Range8.200 EUR – 21.00 EUR
€8.200+283.0% to mean€21.00
# Analysts4
Ownership
Shares Out.23.67M
Float17.31M
Insiders25.37%
Institutions2.77%
Technical
SMA 503.350 (-1.0%)
SMA 2004.128 (-19.7%)
Beta0.83
S&P 52W Chg18.16%
Avg Vol (30d)114.62K
Avg Vol (10d)182.00K
Technical Indicators
RSI (14)50.0
MACD-0.0044
MACD Signal-0.0249
MACD Hist.+0.0206
BB Upper3.399 EUR
BB Middle3.267 EUR
BB Lower3.135 EUR
BB Width8.08%
ATR (14)0.1470 EUR
Vol Ratio (20d)0.91x